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Background
The pandemic outbreak of the novel corona virus disease 
COVID-19 started in Wuhan, Hubei province in China in 
December 2019. With now globally, as of 17 June 2020, 
440,290 registered deaths  and over 8 million confirmed cases 
reported to WHO, it is clear that COVID-19 has an enormous 
impact on many levels (1). There is still investigation going 
on to understand the spectrum of symptoms, epidemiology 
and transmission mechanisms. In the present case we report a 
dermatological manifestation of COVID-19 in an adolescent.
case presentation
On March 30th 2020, a 15-year-old boy with known well-treat-
ed asthma developed dry cough, no fever. His mother showed 
symptoms of COVID-19 on the 23rd of February, and the nasal 
swab was positive on the day after her symptoms started. The 
mother was isolated from the family as from the symptoms 
started until the 3rd of April. Almost at the same time as the 
dry cough the boy developed skin lesions. The skin lesions 
were mildly pruritic symmetric erythematous papules devel-
oping to vesicles located on the hands. On the 13th of April 
the pulmonary symptoms worsened and he was admitted to 
the paediatric department. The tentative diagnosis was asthma 
exacerbation. The chest X-ray was normal, and the throat swab 
and tracheal aspirate for COVID-19 was negative. The tracheal 
secretion culture was negative for bacteria causing atypical 
pneumonia (mycoplasma, legionella, chlamydia) but positive 
for Moraxella catarrhalis, and he was treated with amoxicillin/
clavulanic acid in tablet form for a 10 day period. The blood 
test showed only mildly neutrophilia 7.8 mmol/l, and a normal 
C-reactive-protein (CRP). A lung function test revealed a drop 
in FEV-1 to 45% of what was expected (FEV-1 76% of what was 
expected in November 2019). Because of the severe pulmonary 
symptoms, he was treated with 50 mg prednisolone daily for 
one week. After a week of hospitalization, he was discharged 
with increased doses of asthma medication. 
Fig. 1. Right hand, 6th of April. Fig. 2. Left hand, 6th of April.
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This patient had no recent history or any clinical sign of any 
of these disorders or exposures. He was strongly suspected 
of COVID-19 based on the exposure and the confirmed case 
of the mother and the absence of other causes of the severe 
pulmonary symptoms.
In a recent consensus study the cutaneous manifestations 
of COVID-19 were classified in 5 clinical patterns (3). The 
patterns were described as pseudo-chilblains, other vesicular 
lesions, urticarial lesions, maculopapular eruptions and live-
do or necrosis. The most common manifestation was other 
maculopapulous eruptions (47%) including EM. 
In conclusion, as dermatologists we need to be aware of poss-
ible new and multimorphological cutaneous presentations 
of COVID-19. Cutaneous manifestations can be the initial 
symptom of COVID-19.
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On the 6th of May 2020 the papules on the hands increased 
in size and some of them formed blisters. They healed up 
without scarring, with constantly new elements appearing, 
though only on the hands. Because of the worsening of the 
cutaneous symptoms, he was again examined at the paediatric 
department. The blisters were punctuated and the fluid tested 
(Polymerase Chain Reaction) for COVID-19. The test came out 
negative, as did the IgG antibody test for COVID-19. Blood 
tests were without abnormalities in both red and white blood 
count, CRP, liver and kidney tests. He was discharged without 
any treatment. 
On the 2nd of June the cutaneous symptoms again worsened, 
now with target lesions on hands, forearm, feet and legs. 
Again, swab from the throat and a COVID-19 IgG antibody 
test were negative. After examination on the dermatologic 
department the suspicion of bullous erythema multiforme 
(EM)-like lesions was raised, and he was successfully treated 
with a group 3 corticosteroid creme. 
discussion
In this case we present a patient with suspected COVID-19 with 
cutaneous manifestations clinically consistent with EM. Viral 
infections are the most common causes of EM with Epstein 
Barr-virus, herpes simplex, varicella and cytomegalovirus as 
the most frequently found viruses (2). Drugs are the second 
most common causes of EM (2). 
Fig. 3. Left foot, 5tf of June. Fig. 4. Left arm, 5th of June.
